The global renewable / sustainable laboratory plasticware market size is estimated to grow from $0.47 billion in 2025 to $2.69 billion by 2035, at a CAGR of 19% during the forecast period, till 2035. Currently, the bioplastic based labware segment occupies a higher market share (85%) and is likely to stay dominant during the forecast period. This is primarily due to the fact that bioplastics production consumes 65% less energy than traditional petroleum-based plastics. Further, it is worth menti...

The patient registry software market is estimated to grow from USD 1.81 billion in 2024 to reach USD 2.04 billion in 2025 and USD 5.65 billion by 2035, representing a higher CAGR of 10.7% during the forecast period. According to our patient registry software market report, presently disease registries segment holds the highest share (54%) of the market. Patient registry software market forecast, presently standalone software segment holds the highest share (Over 60%) of the market. It is worth...

The global pharmacy market, valued at USD 2.5 trillion in 2025, is projected to reach USD 2.6 trillion in 2026 and USD 4.1 trillion by 2035, with a 5% CAGR during the forecast period 2026 to 2035. According to the US health department, around 133 million Americans live with at least one chronic disease. In order to address this, the pharmacy industry, comprising both independent stores and chains are offering a wide range of prescription drugs, over-the-counter drugs, medical devices and other...

The global cell therapy packaging market, valued at USD 404 million in 2025, is projected to reach USD 456 million in 2026 and USD 1,225 million by 2035, with a 11.6% CAGR during the forecast period 2026 to 2035. According to our projections, Asia-Pacific captures the major share (41%) in cell therapy packaging market and this trend is unlikely to change in the future. It is further worth highlighting that the cell therapy packaging in Europe is expected to grow at a relatively healthy CAGR (...

The rise in dental tourism and medical aesthetic procedures further bolsters this demand. Industrial players, such as Straumann (Switzerland), Dentsply Sirona (US), ZimVie (US), and Osstem Implant (South Korea), actively launching new products and integrating comprehensive technologies to strengthen their market positions.For instance, in May 2025, Dr. Anurag Kashyap launched a state-of-the-art technique, the syncrystallization intra-oral welder, at RS Cosmetic & Dental Implant Centre, India. Th...

The market for AI in cultured meat has shown robust growth, anticipating growth at a CAGR of 42.7% during the forecast period.In terms of technology, the machine learning segment is securing highest share, driven by the growing usage of machine learning for data collection and analysis for optimizing nutrient media to cultivate meat.

The global monoclonal antibody market size, valued at USD 249.95 billion in 2024, is projected to reach USD 283.86 billion in 2025 and USD 816.33 billion by 2035, representing a CAGR of 11.1% during the forecast period. In terms of applications area, the oncology segment captures the highest market share (nearly 50%) of monoclonal antibody market. As per the regional analysis, North America holds 47% monoclonal antibodies mabs market share. Currently, in vitro production method segment holds the...

The global cold plasma market, valued at USD 2.43 billion in 2024, is projected to reach USD 2.82 billion in 2025 and USD 9.39 billion by 2035, representing a CAGR of 12.8% during the forecast period. Currently, the atmospheric pressure cold plasma segment accounts for 71% of the overall cold plasma market share. Among these, wound healing segment currently holds the highest cold plasma market share (33%). According to our cold plasma market report, currently the hospital sub segment accounts f...

It is worth noting that the growing foundational research on diseases, genomics, gene therapies and targeted drugs has necessitated the demand for oligonucleotide synthesizers in the upcoming years. In addition, the need for advanced diagnostic technologies due to the rising risk of chronic diseases is fueling the demand for oligonucleotide synthesizers.Considering the ongoing demand, several industrial players are encouraging strategic initiatives to develop next generation oligonucleotide synt...

Market players, such as Mckesson (US), ARxIUM (Canada), Capsa Healthcare (US) and KUKA (Germany), are increasingly leveraging strategi initiatives for innovations. For instance, in July 2025, Capsa Healthcare (US) launched its consolidated services pharmacy platform (CSPP), industry’s first integrated scalable system that unifies the central fill automation and enterprise-wide distribution management into single system. Owing to the ongoing demand and rising industrial player initiatives, we b...

The medical transcription software market is estimated to grow from USD 2.47 billion in 2024 to reach USD 2.90 billion in 2025 and USD 10.84 billion by 2035, representing a higher CAGR of 14.1% during the forecast period. Among these, voice recognition segment occupies the largest medical transcription software market share (60%). Voice recognition technology helps to recognize ensure conversion of speech-to-text in real time by using natural language processing algorithms. According to our medi...

The healthcare cybersecurity market size is estimated to grow from USD 20 billion in 2024 to reach USD 24 billion in 2025 and USD 115 billion by 2035, representing a higher CAGR of 17.0% during the forecast period. Currently, malware segment holds the highest share (over 25%) of healthcare cybersecurity market growth. Presently, the on-premises segment also holds the highest share (65%) of the healthcare cybersecurity market size. According to our market analysis, the hospitals segment is holdin...

The global cell and gene therapy manufacturing market size, valued at USD 11.9 billion in 2024, is projected to reach USD 15.1 billion in 2025 and USD 160.0 billion by 2035, representing a CAGR of 26.64% during the forecast period. According to our projection, North America has the highest share (45%) of the market and the trend of dominance is likely to remain unchanged during the forecast period. North American region is currently dominating the industry with the highest share of 45%. . Accord...

Notably, companies, such as Amway (US), Bayer (Germany), and Abbott (US) are focusing on tech-driven personalized nutrition and supplements. For instance, in June 2025, Abbott (US) initiated a new research program (The Healthy Food Rx Program) to deliver personalized meal-based food boxes to the patients with diabetes, offering nutrition education to improve overall health outcomes. This research shows that participants experienced improvement in physical health and achieve greater satisfaction...

Owing to its significances and rising demand for targeted drug delivery devices, several industrial players are undertaking initiatives to develop nanomedicine for drug delivery. For instance, in February 2025, IIT Madras (Indian Institute of Technology, Madras, India) researcher’s team have developed a patented nanotechnology for breast cancer treatment. Owing to the successful outcomes, this researcher team is seeking partnerships with pharmaceutical industries for clinical trials and commer...

The global digital twin market size is estimated to grow from $12.8 billion in 2024 to $240.3 billion in 2035, growing at a CAGR of 30.54% during the forecast period, till 2035. The growth of digital twin market is driven by a number of key factors. For instance, the growing adoption of IoT technology has enabled the development of intricate digital replicas of various industrial processes, assets and systems. This technology, coupled with artificial intelligence and machine learning, has enable...

The global viral vector manufacturing market, valued at USD 704 million in 2024, is estimated to reach USD 799 million in 2025 and USD 2,315 million by 2035, representing a CAGR of 11.23% during the forecast period. Over the past few years, these vectors have emerged as the key pre-requisites for cell and gene therapy manufacturing. It is worth mentioning that, till January 2023, over 25 viral vector based gene therapy products have been approved by different regulatory agencies, worldwide. In t...

The significances offered by the AI in ultrasound has catered to the attention of industrial players for innovation. For instance, in January 2025, Samsung Medison (affiliate of Samsung Electronics, South Korea) launched an AI-powered ultrasound systems for advanced Ob-Gyn applications. Likewise, several market players, such as Medtronic (US), Philips (Netherland) and CloudMex (US) are aiming for designing AI-powered portable / handheld ultrasound scanners which can help in remote diagnosis. The...

Several market players have shown active interest in the field to initiate technological innovations. The primary focus of industrial players is on the development of computational tools, such as CRISPR gene editing for the modification of genetic material. For instance, in February 2025, researchers team at MIT’s McGovern Institute and the Broad Institute of MIT and Harvard found TIGR (Tandem Interspaced Guide RNA), an RNA guides system with diverse functionalities in gene editing. The consi...

Considering the increasing demand, market players are actively undertaking initiatives to encourage technological innovations in this field. For instance, in June 2025, Cosmo Pharmaceutical (Ireland) unveils its first-of-its-kind case study of its medical device software application which is connected with Medtronic GI Genius™ intelligent endoscopy module (an AI-powered platform for gastrointestinal endoscopy), with Apple Vision Pro. Similar to Cosmo Pharmaceutical (Ireland), various market pl...